These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35634245)

  • 1. NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer.
    Schrank TP; Prince AC; Sathe T; Wang X; Liu X; Alzhanov DT; Burtness B; Baldwin AS; Yarbrough WG; Issaeva N
    Oncotarget; 2022; 13():707-722. PubMed ID: 35634245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.
    Schrank TP; Kothari A; Weir WH; Stepp WH; Rehmani H; Liu X; Wang X; Sewell A; Li X; Tasoulas J; Kim S; Yarbrough G; Xie Y; Flamand Y; Marur S; Hayward MC; Wu D; Burtness B; Anderson KS; Baldwin AS; Yarbrough WG; Issaeva N
    Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2216532120. PubMed ID: 37523561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.
    Zhang J; Chen T; Yang X; Cheng H; Späth SS; Clavijo PE; Chen J; Silvin C; Issaeva N; Su X; Yarbrough WG; Annunziata CM; Chen Z; Van Waes C
    Cancer Res; 2018 Aug; 78(16):4613-4626. PubMed ID: 29921694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16
    Pakdel F; Farhadi A; Pakdel T; Andishe-Tadbir A; Alavi P; Behzad-Behbahani A; Ashraf MJ
    Braz J Microbiol; 2021 Mar; 52(1):195-206. PubMed ID: 33169334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
    Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
    Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
    Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features.
    Williams EA; Montesion M; Alexander BM; Ramkissoon SH; Elvin JA; Ross JS; Williams KJ; Glomski K; Bledsoe JR; Tse JY; Mochel MC
    Mod Pathol; 2021 Feb; 34(2):358-370. PubMed ID: 32892208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF3 and NBR1 both influence the effect of the disease-causing CYLD(Arg936X) mutation on NF-κB activity.
    Danis J; Kelemen E; Rajan N; Nagy N; Széll M; Ádám É
    Exp Dermatol; 2021 Nov; 30(11):1705-1710. PubMed ID: 33999445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
    Li YY; Chung GT; Lui VW; To KF; Ma BB; Chow C; Woo JK; Yip KY; Seo J; Hui EP; Mak MK; Rusan M; Chau NG; Or YY; Law MH; Law PP; Liu ZW; Ngan HL; Hau PM; Verhoeft KR; Poon PH; Yoo SK; Shin JY; Lee SD; Lun SW; Jia L; Chan AW; Chan JY; Lai PB; Fung CY; Hung ST; Wang L; Chang AM; Chiosea SI; Hedberg ML; Tsao SW; van Hasselt AC; Chan AT; Grandis JR; Hammerman PS; Lo KW
    Nat Commun; 2017 Jan; 8():14121. PubMed ID: 28098136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in TRAF3 and CYLD that regulate nuclear factor κB and interferon signaling define head and neck cancer subsets harboring human papillomavirus.
    Chen T; Zhang J; Chen Z; Van Waes C
    Cancer; 2017 May; 123(10):1695-1698. PubMed ID: 28295216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers.
    Cui Z; Kang H; Grandis JR; Johnson DE
    Mol Cancer Res; 2021 Jan; 19(1):14-24. PubMed ID: 32883697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
    Mainguené J; Vacher S; Kamal M; Hamza A; Masliah-Planchon J; Baulande S; Ibadioune S; Borcoman E; Cacheux W; Calugaru V; Courtois L; Crozes C; Deloger M; Girard E; Delord JP; Dubray-Vautrin A; Larbi Chérif L; Dupain C; Jeannot E; Klijanienko J; Lameiras S; Lecerf C; Modesto A; Nicolas A; Rouzier R; Saada-Bouzid E; Saintigny P; Sudaka A; Servant N; Le Tourneau C; Bièche I
    Mol Oncol; 2022 Aug; 16(16):3001-3016. PubMed ID: 35398964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus, tobacco, and poor oral hygiene can act synergetically, modulate the expression of the nuclear factor kappa B signaling pathway for the development and progression of head and neck cancer in the Pakistani population.
    Sarwar S; Mulla M; Mulla M; Tanveer R; Sabir M; Sultan A; Malik SA
    Chin Med J (Engl); 2022 Aug; 135(15):1829-1836. PubMed ID: 35838554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.
    Yang X; Cheng H; Chen J; Wang R; Saleh A; Si H; Lee S; Guven-Maiorov E; Keskin O; Gursoy A; Nussinov R; Fang J; Van Waes C; Chen Z
    Cancer Immunol Res; 2019 Nov; 7(11):1760-1774. PubMed ID: 31624067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas.
    Hinić S; Rich A; Anayannis NV; Cabarcas-Petroski S; Schramm L; Meneses PI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
    Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
    J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
    Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
    Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
    Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
    Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.